Quadrature Capital’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $115M | Buy |
521,569
+434,649
| +500% | +$120M | 0.99% | 21 |
|
|
2026
Q1 | $25.7M | Buy |
86,920
+38,910
| +81% | +$11.6M | 0.31% | 82 |
|
|
2025
Q4 | $13.1M | Buy |
48,010
+27,909
| +139% | +$7.58M | 0.13% | 131 |
|
|
2025
Q3 | $5.43M | Sell |
20,101
-24,292
| -55% | -$6.61M | 0.06% | 191 |
|
|
2025
Q2 | $12.2M | Buy |
44,393
+12,186
| +38% | +$3.31M | 0.21% | 104 |
|
|
2025
Q1 | $8.54M | Buy |
32,207
+22,544
| +233% | +$5.56M | 0.19% | 122 |
|
|
2024
Q4 | $2.24M | Sell |
9,663
-8,679
| -47% | -$2M | 0.05% | 295 |
|
|
2024
Q3 | $4.05M | Sell |
18,342
-19,985
| -52% | -$4.14M | 0.09% | 166 |
|
|
2024
Q2 | $7.53M | Buy |
+38,327
| New | +$7.92M | 0.13% | 143 |
|
|
2023
Q4 | – | Sell |
-12,111
| Closed | -$2.42M | – | 1163 |
|
|
2023
Q3 | $2.42M | Sell |
12,111
-31,672
| -72% | -$6.3M | 0.05% | 240 |
|
|
2023
Q2 | $8.11M | Sell |
43,783
-81,633
| -65% | -$15.1M | 0.18% | 129 |
|
|
2023
Q1 | $24M | Sell |
125,416
-202,858
| -62% | -$36.7M | 0.66% | 38 |
|
|
2022
Q4 | $55.2M | Buy |
328,274
+307,051
| +1,447% | +$53.4M | 1.64% | 9 |
|
|
2022
Q3 | $3.76M | Sell |
21,223
-18,149
| -46% | -$3.59M | 0.12% | 168 |
|
|
2022
Q2 | $8.06M | Sell |
39,372
-46,503
| -54% | -$9.86M | 0.34% | 79 |
|
|
2022
Q1 | $20.4M | Buy |
85,875
+69,856
| +436% | +$16.4M | 0.82% | 28 |
|
|
2021
Q4 | $3.66M | Sell |
16,019
-21,616
| -57% | -$4.76M | 0.19% | 93 |
|
|
2021
Q3 | $7.28M | Buy |
+37,635
| New | +$7.62M | 0.26% | 74 |
|
|
2020
Q4 | – | Sell |
-64,708
| Closed | -$10.8M | – | 853 |
|
|
2020
Q3 | $10.8M | Sell |
64,708
-5,721
| -8% | -$964K | 0.62% | 39 |
|
|
2020
Q2 | $11.4M | Buy |
+70,429
| New | +$12.6M | 1.3% | 2 |
|
|
2019
Q2 | – | Sell |
-83,169
| Closed | -$13.7M | – | 466 |
|
|
2019
Q1 | $13.7M | Buy |
+83,169
| New | +$14.7M | 1.17% | 19 |
|
|
2018
Q1 | – | Sell |
-16,421
| Closed | -$2.4M | – | 618 |
|
|
2017
Q4 | $2.4M | Buy |
16,421
+14,357
| +696% | +$2.04M | 0.21% | 125 |
|
|
2017
Q3 | $280K | Sell |
2,064
-19,249
| -90% | -$2.43M | 0.04% | 343 |
|
|
2017
Q2 | $2.67M | Buy |
+21,313
| New | +$2.55M | 0.21% | 112 |
|
|
2017
Q1 | – | Sell |
-165,952
| Closed | -$19.1M | – | 676 |
|
|
2016
Q4 | $19.1M | Buy |
+165,952
| New | +$18.5M | 0.61% | 37 |
|
Other funds holding CME
Quadrature Capital's CME Position: Q2 2026 in Review
Quadrature Capital increased its CME Group (CME) stake by 500% in Q2 2026, buying an estimated $120M and bringing the position to 521,569 shares worth $115M. The position accounts for 0.99% of the portfolio, ranked #21.
Quadrature Capital first reported a position in CME in Q4 2016 and has held it in 25 quarters since. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Quadrature Capital held 521,569 shares of CME Group worth $115M as of Q2 2026.
- Quadrature Capital bought 434,649 CME Group shares in Q2 2026, an estimated $120M.
- CME Group made up 0.99% of Quadrature Capital's portfolio in Q2 2026, its #21 holding.
- Quadrature Capital first reported a position in CME Group in Q4 2016 and has held it in 25 quarters since.
- 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.